These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17418556

  • 1. Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice.
    Coenen KR, Gruen ML, Hasty AH.
    J Nutr Biochem; 2007 Nov; 18(11):727-35. PubMed ID: 17418556
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, Véniant MM.
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y, Su B, Jacobs RL, Kennedy B, Francis GA, Waddington E, Brosnan JT, Vance JE, Vance DE.
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [Abstract] [Full Text] [Related]

  • 6. Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice.
    Plummer MR, Hasty AH.
    J Nutr Biochem; 2008 Oct; 19(10):664-73. PubMed ID: 18280133
    [Abstract] [Full Text] [Related]

  • 7. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR, Hasty AH.
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [Abstract] [Full Text] [Related]

  • 8. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model.
    Hasty AH, Gruen ML, Terry ES, Surmi BK, Atkinson RD, Gao L, Morrow JD.
    J Nutr Biochem; 2007 Feb; 18(2):127-33. PubMed ID: 16781857
    [Abstract] [Full Text] [Related]

  • 9. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM, Hachey DL, Hasty AH.
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 12. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
    Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B, Reitman ML, Gonzalez FJ.
    J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
    [Abstract] [Full Text] [Related]

  • 13. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
    Taleb S, Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R, Esposito B, Clément K, Holvoet P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
    [Abstract] [Full Text] [Related]

  • 14. Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice.
    Lanza-Jacoby S, Miller S, Jacob S, Heumann D, Minchenko AG, Flynn JT.
    J Endotoxin Res; 2003 Dec; 9(6):341-7. PubMed ID: 14733720
    [Abstract] [Full Text] [Related]

  • 15. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M, Glaros E, Leung B, Ng TW, Berbée JF, Deswaerte V, Nawara D, Quinn C, Rye KA, Jessup W, Rensen PC, Meikle PJ, Kritharides L.
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 19. Normal production rate of apolipoprotein B in LDL receptor-deficient mice.
    Millar JS, Maugeais C, Fuki IV, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2002 Jun 01; 22(6):989-94. PubMed ID: 12067909
    [Abstract] [Full Text] [Related]

  • 20. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.
    Netea MG, Demacker PN, Kullberg BJ, Boerman OC, Verschueren I, Stalenhoef AF, van der Meer JW.
    J Clin Invest; 1996 Mar 15; 97(6):1366-72. PubMed ID: 8617867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.